Clinical Trial

ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threatening ischEmia

Study acronym: ORACLE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
ORACLE is a Europe-wide study that will follow 250 people with critical limb-threatening ischemia (CLTI). It aims to see how well orbital atherectomy (OA) works in real-life practice. OA is a procedure that uses a tiny spinning tool to gently remove hard calcium from inside an artery, helping to open the vessel so other treatments-like balloons or stents-can work better. The study focuses on people who have heavily calcified arteries in the femoropopliteal or infrapopliteal areas of the leg.
Protocol Amendment History 1 change
notable Primary completion pushed: 2031-04 -> 2031-08 2026-07-03
Trial Details
NCT Number NCT07270562
Lead Sponsor Cardiovascular and Interventional Radiological Society of Europe
Collaborators: Abbott
Conditions Chronic Limb Threatening Ischemia, Chronic Limb-Threatening Ischemia
Enrollment 250 participants
Start Date 2026-08
Primary Completion 2031-08 (estimated)
Study Completion 2031-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-02